IDH1, ATRX, and TP53 were co-mutated in 3/7 (43%) of our patient cohort, and no other gene was mutated in more than one grade II astrocytoma (Figure 1). The gene discussed is ATRX; the disease is astrocytoma (excluding glioblastoma).